Citigroup Inc Vericel Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Vericel Corp stock. As of the latest transaction made, Citigroup Inc holds 64,847 shares of VCEL stock, worth $3.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,847

Previous 44,697 45.08%

Holding current value

$3.83 Million

Previous $2.05 Million 33.61%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$42.25 - $53.56 $851,337 - $1.08 Million	20,150 Added 45.08%	64,847 $2.74 Million
Q2 2024 Aug 12, 2024	SELL	$41.71 - $52.9 $5.54 Million - $7.03 Million	-132,831 Reduced 74.82%	44,697 $2.05 Million
Q1 2024 May 10, 2024	BUY	$32.52 - $52.33 $3.53 Million - $5.68 Million	108,473 Added 157.08%	177,528 $9.24 Million
Q4 2023 Feb 09, 2024	SELL	$30.85 - $37.09 $68,363 - $82,191	-2,216 Reduced 3.11%	69,055 $2.46 Million
Q3 2023 Nov 09, 2023	BUY	$31.69 - $39.25 $361,329 - $447,528	11,402 Added 19.04%	71,271 $2.39 Million
Q2 2023 Aug 10, 2023	SELL	$29.0 - $38.37 $1.44 Million - $1.9 Million	-49,522 Reduced 45.27%	59,869 $2.25 Million
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $97,498 - $128,117	4,088 Added 3.88%	109,391 $3.21 Million
Q4 2022 Feb 09, 2023	SELL	$17.65 - $27.37 $873,410 - $1.35 Million	-49,485 Reduced 31.97%	105,303 $2.77 Million
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $693,732 - $997,969	30,669 Added 24.71%	154,788 $3.59 Million
Q2 2022 Aug 10, 2022	BUY	$22.88 - $39.45 $1.36 Million - $2.34 Million	59,383 Added 91.73%	124,119 $3.13 Million
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $2.39 Million - $3.27 Million	-75,471 Reduced 53.83%	64,736 $2.48 Million
Q4 2021 Feb 10, 2022	BUY	$35.2 - $52.6 $2.6 Million - $3.88 Million	73,852 Added 111.3%	140,207 $5.51 Million
Q3 2021 Nov 10, 2021	BUY	$46.35 - $59.75 $3.08 Million - $3.96 Million	66,355 New	66,355 $3.24 Million

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account